Agilent Technologies (A) Expected to Post Earnings on Wednesday

Key Points

• Agilent Technologies is expected to report Q3 fiscal 2026 results on August 26 after market close, with analysts forecasting $1.49 in EPS and $1.8415 billion in revenue. The company’s Q3 EPS guidance is $1.48–$1.50, while full-year guidance is $6.00–$6.10.
• Agilent’s previous quarter exceeded expectations, posting $1.49 EPS versus the $1.41 consensus and $1.83 billion in revenue, up 10% year over year.
• Wall Street maintains a “Moderate Buy” consensus, with 15 Buy or Strong Buy ratings and an average price target of $160.24, above the stock’s reported $148.66 price.

Agilent Technologies (NYSE:A - Get Free Report) is projected to issue its Q3 2026 results after the market closes on Wednesday, August 26th. Analysts expect the company to post earnings of $1.49 per share and revenue of $1.8415 billion for the quarter. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Parties can find conference call details on the company's upcoming Q3 2026 earning results page for the latest details on the call scheduled for Wednesday, August 26, 2026 at 4:30 PM ET.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies's revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Agilent Technologies Price Performance

A stock opened at $148.66 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $41.98 billion, a P/E ratio of 29.85, a P/E/G ratio of 2.63 and a beta of 1.25. The business's 50-day moving average is $135.97 and its two-hundred day moving average is $125.68. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $160.27.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. TD Cowen boosted their price objective on Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research report on Thursday, May 28th. Weiss Ratings raised shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, June 2nd. Robert W. Baird lifted their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 26th. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a "neutral" rating and a $150.00 price target for the company. Finally, Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Agilent Technologies has an average rating of "Moderate Buy" and a consensus target price of $160.24.

Hedge Funds Weigh In On Agilent Technologies

Several large investors have recently bought and sold shares of A. State of Wyoming acquired a new stake in shares of Agilent Technologies during the second quarter worth about $35,000. Transamerica Financial Advisors LLC lifted its holdings in shares of Agilent Technologies by 180.8% in the 4th quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company's stock valued at $46,000 after purchasing an additional 217 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $49,000. DV Equities LLC acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at about $54,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at about $58,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source